The table below shows ARROWHEAD PHARMACEUTICALS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$829.45M
$3.55M
$240.74M
$243.23M
$138.29M
$87.99M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$607.16M
$505.87M
$353.19M
-
-
-
SG&A
ARWR annual revenue (10-K history)
ARROWHEAD PHARMACEUTICALS, INC. reported annual revenue of $829.45M for fiscal year 2025. That is up 23258.2% from $3.55M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $158.33K (FY 2016) to $829.45M. Figures come from the company's audited annual reports as filed with the SEC.
